Stephens Investment Management Group LLC Acquires 237,097 Shares of Maximus, Inc. $MMS

Stephens Investment Management Group LLC increased its holdings in shares of Maximus, Inc. (NYSE:MMS) by 49.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 720,943 shares of the health services provider’s stock after purchasing an additional 237,097 shares during the period. Stephens Investment Management Group LLC owned approximately 1.28% of Maximus worth $65,873,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Royal Bank of Canada lifted its holdings in shares of Maximus by 146.2% during the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after buying an additional 11,716 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Maximus by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock valued at $12,321,000 after purchasing an additional 11,754 shares during the last quarter. Jane Street Group LLC boosted its holdings in Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares during the period. Finally, Strs Ohio acquired a new stake in Maximus in the 1st quarter worth $252,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.

Maximus Stock Performance

NYSE MMS opened at $98.26 on Friday. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $98.83. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.77. The stock has a market cap of $5.35 billion, a P/E ratio of 17.67 and a beta of 0.56. The company’s 50-day simple moving average is $86.85 and its 200 day simple moving average is $84.10.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a net margin of 5.87% and a return on equity of 25.23%. The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same period in the previous year, the firm posted $1.46 earnings per share. The firm’s revenue for the quarter was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.3%. This is a positive change from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date is Friday, February 13th. Maximus’s dividend payout ratio (DPR) is currently 23.74%.

Insider Transactions at Maximus

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the transaction, the insider directly owned 19,542 shares in the company, valued at $1,697,027.28. This represents a 17.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is owned by corporate insiders.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.